The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline. Furthermore, ...

In alignment with the FDA’s aim to phase out petroleum-based dyes, the agency has approved three color additives from natural ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...

Volpara Health, a Lunit a company and global leader in software for the early detection of breast cancer, today applauded the significant advancement in breast health management with BreastScreen ...

By Julie Steenhuysen CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

Democratic Texas Rep. Jasmine Crockett rambled about “education” when a reporter asked her to describe the Democratic Party’s ...

Thyme Care, the leading value-based cancer care enabler, today announced a significant expansion of its survivorship program ...

In an exclusive interview with Meet the Press, Sen. Raphael Warnock (D-Ga.) does not answer directly to a former Harris ...

In an exclusive interview with Meet the Press, Speaker of the House Mike Johnson (R-La.) reacts to Elon Musk’s criticism of ...

The results, presented at the American Society of Clinical Oncology meeting in Chicago, mark the first use of a blood test ...